Alphatec Holdings (ATEC) Cash & Equivalents (2010 - 2026)
Alphatec Holdings' (ATEC) quarterly Cash & Equivalents came in at $139.9 million in Q1 2026, down 8.7% year-on-year from $153.2 million in Q1 2025, and down 12.99% quarter-over-quarter from $160.8 million in Q4 2025.
Alphatec Holdings (ATEC) Cash & Equivalents (2010 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Cash & Equivalents across 17 years of filings, most recently posting $139.9 million for Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $139.9 million, down 8.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $139.9 million (down 8.7% YoY), and the FY2025 annual result was $160.8 million, up 15.82% from the prior year.
- Cash & Equivalents came in at $139.9 million for Q1 2026 at Alphatec Holdings, down from $160.8 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $221.0 million in Q4 2023 to a low of $81.0 million in Q3 2024.
- The 5-year median for Cash & Equivalents is $138.8 million (2024), against an average of $131.9 million.
- Across the five-year window, Cash & Equivalents plunged 54.77% in 2022 and soared 160.9% in 2023, its largest moves.
- Alphatec Holdings' Cash & Equivalents stood at $84.7 million in 2022, then surged by 160.9% to $221.0 million in 2023, then slumped by 37.17% to $138.8 million in 2024, then climbed by 15.82% to $160.8 million in 2025, then retreated by 12.99% to $139.9 million in 2026.
- The last three Cash & Equivalents figures came in at $139.9 million (Q1 2026), $160.8 million (Q4 2025), and $155.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Alphatec Holdings | 1.34 Bn | 1.20 Bn | 136.48 Mn | 139.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.91 Mn |
| Dec 31, 2025 | 160.81 Mn |
| Sep 30, 2025 | 155.74 Mn |
| Jun 30, 2025 | 157.06 Mn |
| Mar 31, 2025 | 153.24 Mn |
| Dec 31, 2024 | 138.84 Mn |
| Sep 30, 2024 | 80.98 Mn |
| Jun 30, 2024 | 99.83 Mn |
| Mar 31, 2024 | 144.09 Mn |
| Dec 31, 2023 | 220.97 Mn |
| Sep 30, 2023 | 122.53 Mn |
| Jun 30, 2023 | 101.02 Mn |
| Mar 31, 2023 | 116.70 Mn |
| Dec 31, 2022 | 84.70 Mn |
| Sep 30, 2022 | 106.11 Mn |
| Jun 30, 2022 | 107.47 Mn |
| Mar 31, 2022 | 151.81 Mn |
| Dec 31, 2021 | 187.25 Mn |
| Sep 30, 2021 | 223.87 Mn |
| Jun 30, 2021 | 76.58 Mn |